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We have previously described a Korean family afflicted with
spinocerebellar ataxia type 2 (SCA2) parkinsonism in which genetic
analysis revealed CAG expansion of 40 repeats in the ATXN2 gene.1
The affected members presented with levodopa-responsive parkinson-
ism without cerebellar ataxia. Some showed motor fluctuation and
dyskinesia, further mimicking idiopathic Parkinson’s disease (PD).
Herein, we report a member of this family who developed jaw-opening
and lingual-protrusion dystonia as the chief presentation.
Case report
The patient, no. 32 in the pedigree (Fig. 1), presented to the clinic
at age 58. He reported involuntary jaw opening that persisted for
2 months, which led to disabling difficulties in swallowing and speech.
A sense of his leg dragging and a gait disturbance accompanied the
symptoms. There was no history of exposure to antipsychotics or other
medications.
Upon examination, oromandibular dystonia was found to be
prominent. Involuntary jaw opening and tongue protrusion continued
with fluctuation, causing difficulty in speech and chewing, but he did
not lose weight. These involuntary movements were reported to
fluctuate with no particular diurnal pattern, and no definite triggering
or suppressive factor was identified. No sensory trick was found.
Systemic evaluation revealed bilateral hyper-reflexive deep-tendon
reflex, mildly stooped posture, and parkinsonian gait. There was
no sign of lower motor lesion, including weakness, muscle atrophy,
or fasciculation. Ataxia, dysmetria, and extraocular movement abnor-
mality were not observed upon careful examination. Dystonia was
absent in other parts of the body.
Dopaminergic agents, anticholinergics, baclofen, and clonazepam
were ineffective or not consistently effective for his oromandibular
dystonia. A maximum 600 mg daily dosage of levodopa, 3 mg of
pramipexole, 1 mg of rasagiline, 6 mg of biperiden, 300 mg of
amantadine, 30 mg of baclofen, and 1.5 mg of clonazepam was serially
administered over 4 years. The patient committed suicide at age 62.
The initial differential diagnosis of his presentation included Wilson’s
disease, X-linked dystonia parkinsonism, Fahr disease, and neurode-
generation with brain iron accumulation before it was revealed that
he was a member of the SCA2 family. Magnetic resonance imaging
was unremarkable, with no focal atrophy or iron accumulation.
Decreased uptake in the anterior part of both striata was revealed by
[18F]-N-(3-fluoropropyl)-2b-carbon ethoxy-3b-(4-iodophenyl) nortro-
pane ([18F]-FP-CIT) positron emission tomography (Fig. 2). Both
horizontal and vertical saccadic velocity were normal using video-
oculography. Because of his family history, the patient was tested for
SCA2 with a positive result, and the same CAG expansion of 40 as in
other affected family members.
Freely available online
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org Columbia University Libraries1
Discussion
This is the first case of SCA2 that presented with lingual-protrusion
dystonia as the chief and initial complaint, accompanied by subtle
parkinsonian features. This case demonstrates that intrafamilial
heterogeneity exists within the single SCA2 kindred. In the previous
report on this family, we suggested that SCA2 parkinsonism be
considered in the diagnostic workup of familial PD even without
cerebellar ataxia. This case supports broadening the indication of the
workup.
As detailed in Kim et al.,1 the other affected family members had
levodopa-responsive parkinsonism without cerebellar ataxia. No sign
of cerebellar dysfunction was found on careful follow-up examination
and video-oculography. Structural and functional brain imaging in
this family showed no cerebellar atrophy but indicated presynaptic
dopaminergic degeneration with a spared post-synaptic dopaminergic
Figure 1. Pedigree of the Spinocerebellar Ataxia Type 2 Korean Family. Adopted and revised from the pedigree in Kim et al.1 The red arrow indicates
no. 32, the proband.
Figure 2. Structural and Functional Brain Imaging of the Patient. (A) Reduced dopamine transporter density in the anterior parts of both striata as shown
in [18F]-FP-CIT positron emission tomography performed at age 59. (B,C) Brain magnetic resonance imaging at age 59 showed no definite cerebellar atrophy.
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system in the striatum. Sequencing was performed in patients 12
and 29. The expanded allele with 40 CAG repeats had four
CAA interruptions ((CAG)8CAA(CAG)8CAA(CAG)8CAA(CAG)4CAA
(CAG)8) whereas the normal allele with 22 CAG repeats showed two
CAA interruptions ((CAG)8CAA(CAG)4CAA(CAG)8). LRRK2, VPS35,
EIF4G1, SNCA, and ATXN3 were all negative.1 Notably, subjects 14
and 34 (Fig. 1) showed dystonia and blepharospasm during the long
course of the disease, but their symptoms remained mild until death
or last follow-up.
While dystonia is observed in patients with parkinsonism, it is
typically not the initial or main presentation, especially in the oroman-
dibular area.2 The prevalence of dystonia in SCA2 ranges from 14%
to 18.1% but is as high as 61% in some reports.3–5 Jaw-opening
dystonia has been reported in SCA2 patients,6 but only one case
of lingual-protrusion dystonia is described in SCA2. That patient
had a 27-year history of cerebellar symptoms and was already
wheelchair-bound when she developed jaw-opening and lingual-
protrusion dystonia.3
The mechanism of oromandibular dystonia in this SCA2 patient
remains unclear. In contrast to the parkinsonian symptoms of other
family members, dystonia in this patient remained unresponsive to
dopaminergic treatment, even though there was a severe decrease in
dopamine transporter (DAT) ligand binding in the anterior part of the
striatum (Fig. 2). This finding implies that presynaptic dopaminergic
denervation was less likely to be related to dystonia in this patient.
Cerebellar pathophysiology may have contributed to the dystonia via
interconnection with basal ganglia,7 although there was no overt sign
of cerebellar dysfunction either clinically or radiologically.
With regard to imaging studies of the dopaminergic system, several
reports have described prominent striatal DAT loss in SCA2 patients
without parkinsonism.8–10 Similarly, autopsies of two SCA2 patients
revealed significant nigral degeneration.11 Another autopsy study
suggested that the combined degeneration of the subthalamic nucleus
(STN) may be responsible for the lack of clinical parkinsonism in
typical SCA2 and SCA3 patients despite presynaptic dopaminergic
deficits. An autopsy of the only patient with parkinsonism in the study
revealed sparing of the STN, in contrast to the other patients.9
Considering the efficacy of STN deep brain stimulation in refractory
dystonia,12 there is also a possibility that sparing of the STN in certain
SCA2 patients may play a role in the development of dystonia as well
as parkinsonism.
This case report emphasizes prominent intrafamilial heterogeneity
in clinical manifestations of a large SCA2 parkinsonism family in
Korea. Modifying gene or epigenetic factors altering the phenotype of
SCA2 should be further investigated.
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